Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?

Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?

Platinum-based chemotherapy has been the cornerstone of systemic treatment in ovarian cancer. Since no validated molecular predictive markers have been identified yet, the response to platinum-based chemotherapy has been evaluated clinically, based on platinum-free interval. The new promising marker...

Full description

Bibliographic Details
Main Authors: Marketa Bednarikova, Jitka Hausnerova, Lucie Ehrlichova, Kvetoslava Matulova, Eliska Gazarkova, Lubos Minar, Vit Weinberger
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
SLFN11
ovarian cancer
high-grade serous carcinoma
DNA-damaging agents
PARPi
chemoresistance
Online Access:https://www.mdpi.com/2072-6694/14/10/2353

Internet

https://www.mdpi.com/2072-6694/14/10/2353

Similar Items